Skip to main content

Advertisement

Hydroa vacciniforme as a differential diagnosis of atopic dermatitis

Article metrics

  • 694 Accesses

Background

Hydroa Vacciniforme is a rare photosensitivity disorder predominantly affecting children. It is characterized by recurrent vesiculopapular eruptions that evolve into necrotic crusts on sun-exposed areas.

Methods

Case report of a 13-year-old female patient who has been referred to the Allergy Clinic for evaluation of severe Atopic Dermatitis, and had her definitive diagnosis established by skin biopsy.

Results

Patient’s symptoms started at age 4, presenting with vesiculopapular eruptions and pruritus on photo-exposed areas, evolving into crusts. She had been treated with anti-histamines and topical steroids for several years, with no improvement. Sometimes the patient referred other associated symptoms, including dizziness, dyspnea, chest pain and strong pain in the thighs. Additional treatments included oral corticosteroids, moisturizers, sunscreen filter factor 30 and cyclosporine. On physical exam, the patient presented erythematous papules, infiltrated, associated with lichenification, crusts and chafing on the surface of the exposed areas in the upper limbs, anterior chest, lumbar region and lower limbs, and erythematous plaques in the nasal and malar region. Differential diagnosis included Atopic Dermatitis, Besnier’s Prurigo, Idiopathic Prurigo, Subacute Erythematosus Lupus, Protoporphyria and Contact Dermatitis. At our hospital she underwent skin biopsy, and the results showed characteristic features of Hydroa vacciniforme. The patient now is being treated with chloroquine 250mg/day, Pimecrolimus cream twice daily on the face, mometasone once a week, hydroxyzine 25mg twice daily, and sunblock factor 30. She reports great improvement of symptoms.

Conclusions

We described a rare case of Hydroa Vacciniforme, demonstrating the importance of this disease in differential diagnosis of Atopic Dermatitis. Correct diagnosis would avoid inappropriate treatment and related adverse side effects.

Consent

Written informed consent was obtained from the patient for publication of this abstract and any accompanying images. A copy of the written consent is available for review by the Editor of this journal.

Author information

Correspondence to Lucas Brom.

Rights and permissions

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark